Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy.

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• Septic cardiomyopathy is characterized by high morbidity and mortality.
• The precise role of microRNA-22 (miR-22) in this condition remains unclear.

Purpose of the Study:

• To investigate the role of miR-22 in septic cardiomyopathy.
• To elucidate the underlying molecular mechanisms of miR-22's action.

Main Methods:

• Utilized miR-22 cardiac-specific knockout (miR-22^cKO) and transgenic (miR-22^cOE) mice subjected to cecal ligation and puncture (CLP) to induce sepsis.
• Performed echocardiography, measured serum cardiac biomarkers (LDH, CK-MB), and assessed apoptosis, autophagy, and mitochondrial function.
• Validated findings in primary cardiomyocytes treated with lipopolysaccharide (LPS) in vitro.

Main Results:

• miR-22^cKO mice exhibited alleviated cardiac dysfunction, reduced serum LDH and CK-MB levels post-CLP.
• Knockout of miR-22 led to decreased apoptosis, enhanced autophagy, and improved mitochondrial function.
• Inhibition of miR-22 promoted autophagic flux, evidenced by increased LC3II/GAPDH ratio and decreased p62 levels.

Conclusions:

• Cardiac-specific knockout of miR-22 confers a cardioprotective effect against sepsis.
• miR-22 inhibition may protect the heart by upregulating autophagy and downregulating apoptosis, potentially via sirt1.
• Targeting miR-22 presents a novel therapeutic strategy for septic cardiomyopathy.